PubMed: 20219669 AOD 9604 Reduces Leptin Levels and Improves Leptin Sensitivity in High-Fat Diet Obese Rats animal Liu B, Duong T, Nusser J, et al
Oral BPC157 has been evaluated in models of gastric ulcers, colitis, and gut permeability, where it has shown protective and prohealing effects on the mucosal lining
Most episodes resolve within 3-5 days at a stable dose
women comprised 67.6%, and most had dyslipidemia or hypertension at baseline
Unknown Long-Term Effects : Human clinical data on BPC-157 covers fewer than 30 participants across 3 published pilot studies as of 2026
25 years ago, I needed to setup what was in essence an "authorized trading partners" process for sales of pseudoephedrine with BASF -- when the pseudo diversion and meth lab problem exploded